QC
INDV icon

Quadrature Capital’s Indivior Pharmaceuticals INDV Stock Holding History

Quadrature Capital’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.59M Buy
38,864
+14,096
+57% +$511K 0.01% 583
2026
Q1 		$755K Buy
+24,768
New +$818K 0.01% 659
2025
Q4 		– Sell
-8,600
Closed -$207K – 1451
2025
Q3 		$207K Buy
+8,600
New +$180K ﹤0.01% 779
2024
Q2 		– Sell
-71,113
Closed -$1.52M – 1318
2024
Q1 		$1.52M Buy
+71,113
New +$1.34M 0.03% 364

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quadrature Capital's INDV Position: Q2 2026 in Review

Quadrature Capital increased its Indivior Pharmaceuticals (INDV) stake by 57% in Q2 2026, buying an estimated $511K and bringing the position to 38,864 shares worth $1.59M. The position accounts for 0.01% of the portfolio, ranked #583.

Quadrature Capital first reported a position in INDV in Q1 2024 and has held it in 4 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Quadrature Capital held 38,864 shares of Indivior Pharmaceuticals worth $1.59M as of Q2 2026.
  • Quadrature Capital bought 14,096 Indivior Pharmaceuticals shares in Q2 2026, an estimated $511K.
  • Indivior Pharmaceuticals made up 0.01% of Quadrature Capital's portfolio in Q2 2026, its #583 holding.
  • Quadrature Capital first reported a position in Indivior Pharmaceuticals in Q1 2024 and has held it in 4 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.